Peri-articular injection of an analgesic mixture in primary total hip arthroplasty: an effective strategy for pain control during the first post-operative day

Bautista, María; Muskus, Meilyn; Llinás, Adolfo; Bonilla, Guillermo; Guerrero, C.; Moyano, Jairo

doi:10.1007/s00264-018-3788-z

Cited by 6 publications

(5 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Meta-analyses based on studies employing methylprednisolone and placebo present a significant difference in pain assessment using the VAS scale in first 48 hours postoperatively and opioid agents administered parenterally per 1 kg of body mass [2,4,6,18,20,21,[26][27][28]. Also confirmed by the present study ( Figs.…”

Section: Discussionsupporting

confidence: 84%

The effect of pre-operative high doses of methylprednisolone on pain management and convalescence after total hip replacement in elderly: a double-blind randomized study

Gądek

Liszka

Zając

2020

International Orthopaedics (SICOT)

View full text Add to dashboard Cite

Purpose The aim of the study was to assess whether administration of a single dose of methylprednisolone in the group patients above 65 years of age will be effective in complex analgesic management after total hip arthroplasty (THA). Methods Seventy-seven patients above 65 years old were double-blind randomized into two: the study and controls groups. Pre-operatively, the study group received as a single dose of 125 mg intravenous methylprednisolone, while the others saline solution as placebo. Peri-operatively, all the patients were administered opioid and nonopioid analgesic agents. We measured the levels of inflammatory markers (leukocytosis, C-reactive protein—CRP), pain intensity level (visual analog scale—VAS; numerical rating scale—NRS), the life parameters, and noted complications. Results Following administration of methylprednisolone were significantly lower levels of CRP on all the four post-operative days; leukocytosis on the second day; the VAS/NRS score at rest after six, 12, and 18 hours post-operatively, diminished the dose of parenteral opioid preparations (oxycodone hydrochloride), the duration of analgesia by peripheral nerve block was significantly higher as compared with the placebo group (p < 0.000001). No infectious complications were noted; there was one patient who developed post-operative delirium. Conclusion A single dose of methylprednisolone significantly reduces the level of post-operative pain at rest on the day of THA in the group patients above 65 years of age, decreases the dose of opioid analgesic agents, and significantly decreases the level of inflammatory markers, without infectious processes.

show abstract

Section: Discussionsupporting

confidence: 84%

The effect of pre-operative high doses of methylprednisolone on pain management and convalescence after total hip replacement in elderly: a double-blind randomized study

Gądek

Liszka

Zając

2020

International Orthopaedics (SICOT)

View full text Add to dashboard Cite

show abstract

“…St Michael’s HS [ 611 , 433 ] 2. Toronto Western HS [ 15 , 40 , 48 – 50 , 54 , 68 , 107 , 603 , 411 , 456 ] Winnpeg University of Manitoba [ 300 , 366 , 477 , 487 , 492 ] South America Colombia Bogota HS Universitario Fundación Santa Fe de Bogotá [ 220 , 291 , 376 , 615 ] United States of America California 1. CJRR [ 146 , 150 , 215 , 317 , 353 , 365 ] 2.…”

Section: Resultsmentioning

confidence: 99%

Global mapping of institutional and hospital-based (Level II–IV) arthroplasty registries: a scoping review

Zgouridou,

Kenanidis,

Potoupnis

et al. 2023

Eur J Orthop Surg Traumatol

View full text Add to dashboard Cite

Purpose Four joint arthroplasty registries (JARs) levels exist based on the recorded data type. Level I JARs are national registries that record primary data. Hospital or institutional JARs (Level II–IV) document further data (patient-reported outcomes, demographic, radiographic). A worldwide list of Level II–IV JARs must be created to effectively assess and categorize these data. Methods Our study is a systematic scoping review that followed the PRISMA guidelines and included 648 studies. Based on their publications, the study aimed to map the existing Level II–IV JARs worldwide. The secondary aim was to record their lifetime, publications’ number and frequency and recognise differences with national JARs. Results One hundred five Level II–IV JARs were identified. Forty-eight hospital-based, 45 institutional, and 12 regional JARs. Fifty JARs were found in America, 39 in Europe, nine in Asia, six in Oceania and one in Africa. They have published 485 cohorts, 91 case-series, 49 case–control, nine cross-sectional studies, eight registry protocols and six randomized trials. Most cohort studies were retrospective. Twenty-three per cent of papers studied patient-reported outcomes, 21.45% surgical complications, 13.73% postoperative clinical and 5.25% radiographic outcomes, and 11.88% were survival analyses. Forty-four JARs have published only one paper. Level I JARs primarily publish implant revision risk annual reports, while Level IV JARs collect comprehensive data to conduct retrospective cohort studies. Conclusions This is the first study mapping all Level II–IV JARs worldwide. Most JARs are found in Europe and America, reporting on retrospective cohorts, but only a few report on studies systematically.

show abstract

“…It is worth mentioning that liposomal bupivacaine has been associated with more superior outcomes in patients undergoing THR compared to traditional bupivacaine [29]. Apart from that, a considerable number of studies have reported that LIA is associated with more sufficient postoperative analgesia and less opioid consumption [30][31][32][33][34]. Furthermore, another recent study has suggested that LIA not only represents an effective method of analgesia but it also leads to a reduced length of stay in the hospital [35].…”

Section: Intraoperative Periarticular Injectionmentioning

confidence: 99%

Perioperative Pain Management in Patients Undergoing Total Hip Arthroplasty: Where Do We Currently Stand?

Tsinaslanidis

Mahajan

2020

Cureus

View full text Add to dashboard Cite

Total Hip replacement (THR) is a well-discussed topic, and it offers excellent results in patients suffering from end-stage osteoarthritis (OA). However, despite the fact that patients can fully bear weight immediately after the surgery, THR is often associated with a great amount of postoperative pain affecting recovery and rehabilitation. Therefore, the efficient management of pain is of paramount importance. The aim of this review is to examine all the currently available strategies of pain management such as preemptive analgesia (PA), patient-controlled analgesia (PCA), and the various types of anesthesia that are used during the operation. With that objective in mind, we conducted our research by searching through the PubMed database for articles published in 2015 and after. For purely clinical reasons, we have attempted to classify all the best available evidence into three major categories: prior to surgery, during the surgery, and after the surgery. Multimodal analgesia seems to play a major role in the perioperative care of patients undergoing total hip arthroplasty (THA). Therefore, a considerable number of studies have been conducted analyzing all the current strategies that aim to minimize perioperative pain and consequent complications.

show abstract

Peri-articular injection of an analgesic mixture in primary total hip arthroplasty: an effective strategy for pain control during the first post-operative day

Abstract: Level II, cohort study.

Cited by 6 publications

References 26 publications

The effect of pre-operative high doses of methylprednisolone on pain management and convalescence after total hip replacement in elderly: a double-blind randomized study

The effect of pre-operative high doses of methylprednisolone on pain management and convalescence after total hip replacement in elderly: a double-blind randomized study

Global mapping of institutional and hospital-based (Level II–IV) arthroplasty registries: a scoping review

Perioperative Pain Management in Patients Undergoing Total Hip Arthroplasty: Where Do We Currently Stand?

Contact Info

Product

Resources

About